- Top Republicans Seeking to Question Leaders of Lobbying Firm Connected to Hunter Biden
By Zachary Stieber
Top Republicans in the U.S. House of Representatives announced on Nov. 29 that they’re seeking interviews with executives at Blue Star Strategies, ...
- These Experts Advocated for Lockdowns; Now They Say They Were Wrong
By Katie Spence
As the dust settles from the COVID-19 pandemic and the fallout over lockdown policies becomes more pronounced, some lockdown proponents, like New ...
- US Spends Billions on Overseas Wars, But Who Really Benefits
By Andrew Thornebrooke
Concerns over incentivizing global conflicts are rising as the Biden administration requests more than $105 billion in supplemental security spending.
The administration says the money, ...
- Gag Order Reveals Partisan Nature of Trial, Trump Attorneys Argue
By Catherine Yang
Attorneys for former President Donald Trump in a civil fraud case against him in New York state filed a 1,902-page brief on Nov. 27 ...
- Biden Continues to Face Deteriorating Poll Numbers
By Emel Akan
Over the last two years, President Joe Biden made great efforts to rally fractured Democrats behind his “Build Back Better” plan in ...
- Gun Ownership in America Hits Record High
By Michael Clements
Gun ownership among U.S. citizens is at its highest in more than two decades. According to a recent NBC News poll, more ...
- NY GOP Mull House Speaker’s Influence on 2024 Elections
By Juliette Fairly
When former New York Republican Congressman John Faso was competing for office in 2018, former Congressman Paul Ryan (R-Wis.), who was Speaker ...
- Driverless Cars in California Immune from Traffic Tickets under Current Laws: Report
By Jill McLaughlin
Autonomous cars driving city streets in California have run red lights, blocked emergency vehicles, and injured a pedestrian. But can they get ...
- 26 Lawmakers Will Not Be Seeking Reelection in 2024—Here’s the List
By Naveen Athrappully
Several lawmakers from the GOP and Democratic parties will not be running for reelection in the 2024 race, with most retiring and ...
- US Warship Shoots Down Multiple Drones Fired From Yemen
By Aldgra Fredly
A U.S. warship shot down “multiple one-way attack drones” fired from Houthi-controlled areas in Yemen while it was cruising on the Red ...
- No Sign of Terrorism in Rainbow Bridge Explosion, Says NY Governor
By Caden Pearson
The crash and explosion at a U.S.-Canadian border checkpoint at the Rainbow Bridge in Niagara Falls was not a terrorist attack, New ...
- Arizona County Votes Again Against Hand-Counting 2024 Election Ballots
By Jack Phillips
Arizona’s Mohave County on Nov. 20 voted against hand-counting all ballots for the 2024 election—the second time the county has done so ...
![Recent documents disclosed as part of a Freedom of Information Act (FOIA) lawsuit against the U.S. Food and Drug Administration (FDA) show the agency knew its safety monitoring system was “not sufficient” for assessing the risk of heart conditions associated with Pfizer’s COVID-19 vaccine when it licensed the company's “Comirnaty” vaccine. Documents also reveal numerous manufacturing problems in Pfizer batches released to the public and show the FDA knew about a phenomenon known as vaccine-associated enhanced disease (VAED) in those vaccinated who experience breakthrough COVID-19. The FDA released the final batch of documents it relied upon in licensing Pfizer’s Comirnaty COVID-19 vaccine for ages 16 and up—more than 800 days after the agency approved the shot. The memo states: “The CBER Sentinel Program is NOT sufficient to assess the serious risks of myocarditis and pericarditis, and subclinical myocarditis associated with COMIRNATY (BNT162b2) in lieu of PMR safety studies under FDAAA [Food and Drug Administration Amendments Act]. “At the time of BLA [Biologics License Application] approval, the data sources in the CBER Sentinel Program are not sufficient to identify the outcomes due to lack of sufficient power to assess the magnitude of risk in patients 12-30 years of age. In addition, CBER Sentinel Program is not sufficient to follow up cases for recovery status and long-term sequelae, or for identification and characterization of subclinical myocarditis cases.” Cardiac Disorders Higher in Vaccine Trial Group According to an Aug. 23, 2021, BLA Clinical Review Memorandum, there were more cardiac disorders in trial participants who received Pfizer’s COVID-19 vaccine compared to the placebo group and more instances of tachycardia in the younger vaccinated age group. Cardiac conditions were reported as the cause of death in nine participants 25 to 128 days after having received at least one dose of Pfizer’s COVID-19 vaccine, including seven cases of cardiac arrest, one case of cardiovascular disease, and one case of congestive heart failure. Five cardiac-related deaths in the placebo group occurred 15 to 81 days after having received a placebo, including two cases of myocardial infarction, one aortic rupture, and two cardiac arrests. “Because COVID-19 mRNA and its Spike protein are found in the human heart at autopsy causing inflammation and heart damage, it is incontrovertible that the COVID-19 vaccines are cardiotoxic,” cardiologist Dr. Peter McCullough told The Epoch Times in an email. “Younger individuals with healthy hearts take up more of the damaging vaccine into the cardiac tissue resulting in symptoms of chest pain, palpitations, fluctuations in blood pressure, dizziness, and sadly, some, end up with cardiac arrest either during exercise or in the early morning waking hours. At both time periods, an internal surge of adrenalin appears to be the trigger for the fatal arrhythmia in those with COVID-19 vaccine myocarditis,” he added. Despite nearly double the number of reported cardiac events in vaccine recipients versus placebo recipients, the FDA concluded the deaths were “unlikely to be related to vaccination.” “As a cardiologist, these serious adverse events are unacceptable,” Dr. McCullough said. “I have called for all COVID-19 vaccines to be removed from the market with an urgent push for research strategies to prevent cardiac death after injection.” Vaccines Released Despite Manufacturing Issues According to the Pfizer Andover Response to Form FDA 483 included in the released documents, numerous manufacturing issues and inadequacies in quality oversight were also identified. Several batches of COVID-19 vaccines were flagged for deviating from product quality standards, yet the affected batches were released to the public in various lots, the numbers of which were redacted. In November 2021, whistleblower Brook Jackson, who worked as a regional director at testing sites by Pfizer contractor Ventavia, told the British Medical Journal that Pfizer's trial was riddled with issues. Ms. Jackson said the company “falsified data, unblinded patients, employed inadequately trained vaccinators, and was slow to follow up on adverse events reported in Pfizer’s pivotal phase III trial.” Ms. Jackson, a trained clinical trial auditor with more than 15 years of experience in clinical research coordination and management, emailed a complaint to the FDA and was fired later that day. She subsequently filed a lawsuit against Ventavia and Pfizer, alleging Pfizer had defrauded the government while developing its COVID-19 vaccine. FDA Acknowledges Vaccine-Associated Enhanced Disease In its Pharmacovigilance Plan Review Memorandum, the FDA referenced a condition called “vaccine-associated enhanced disease.” According to the journal Vaccine, VAED is the modified presentation of a clinical infection affecting individuals exposed to the wild-type pathogen after having received a vaccine for the same pathogen. In its memo, the FDA stated there are reported deaths in the Vaccine Adverse Event Reporting System (VAERS) in patients reported to be fully vaccinated. Although the agency said that passive surveillance and spontaneous adverse event reporting generally cannot be used to conclude vaccine effectiveness because of the lack of a control group, reporter bias, and underreporting, “severe manifestations and death from COVID-19” increase the possibility of developing VAED, which has “overlapping clinical manifestations with natural SARS-CoV-2 infection, making it difficult to differentiate VAED from severe COVID-19 disease in individual VAERS reports.” The FDA said Pfizer was assessing the condition in its continuation of Phase 3 clinical studies and active surveillance studies. VAED has been observed in other vaccine trials involving the dengue virus, respiratory syncytial virus, and measles. FDA Took Over 800 Days to Release Data The Public Health and Medical Professionals for Transparency (PHMPT), a nonprofit consisting of public health and medical professionals, scientists, and journalists, filed a FOIA lawsuit against the FDA in September 2021 to force the release of hundreds of thousands of documents relied upon by the agency in licensing Pfizer’s COVID-19 vaccine for individuals age 16 and older. Even though the FDA said in a news release it was committed to “ensuring full transparency, dialogue and efficiency” regarding COVID-19 vaccines and reiterated its commitment to full transparency when it licensed Pfizer's Comirnaty vaccine, they wanted 75 years to produce an estimated 451,000 documents at a rate of 500 pages per month. It previously estimated it had 329,000 pages of responsive records and wanted 55 years to release them to the public. Attorney Aaron Siri, who filed the lawsuit on behalf of the group, said the federal government was shielding Pfizer from liability, gave it billions of dollars, and forced Americans to get vaccinated while preventing the safety and efficacy data supporting the licensure of Pfizer’s COVID-19 vaccine from being released until the year 2076. Yet it only took 108 days from when Pfizer started producing records to the agency for the FDA to license its vaccine.](https://www.usnn.news/wp-content/uploads/2023/12/Final-Batch-of-Pfizer-Documents-Released-Shows-FDA-Knew-Safety-Monitoring-System-Was-Not-Sufficient.jpg "Final Batch of Pfizer Documents Released Shows FDA Knew Safety Monitoring System Was 'Not Sufficient' 8")
